Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 3/20 | 0.48 |
| ▸ | ELANE | P08246 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | MGLL | Q99685 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1470251 | 0.95 | ELANE (0.47) | NAAAELANEALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL1471894 | 0.84 | ELANE (0.51) | ELANEALDH1A1RAB9ASMN1; SMN2HTT | |
| SCHEMBL1470281 | 0.80 | ELANE (0.53) | ELANEALDH1A1RAB9ASMN1; SMN2HTT | |
| SCHEMBL1471982 | 0.79 | ALDH1A1 (0.51) | ELANEALDH1A1RAB9ASMN1; SMN2HTT | |
| SCHEMBL8375161 | 0.78 | ELANE (0.50) | ELANEALDH1A1RAB9ASMN1; SMN2HTT | |
| SCHEMBL8371946 | 0.78 | ELANE (0.50) | ELANEALDH1A1RAB9ASMN1; SMN2HTT | |
| SCHEMBL7611800 | 0.78 | ELANE (0.50) | ELANEALDH1A1RAB9ASMN1; SMN2HTT | |
| SCHEMBL28629364 | 0.76 | ALDH1A1 (0.51) | ELANEALDH1A1RAB9ASMN1; SMN2HTT | |
| SCHEMBL27868074 | 0.76 | ELANE (0.49) | ELANEALDH1A1RAB9ASMN1; SMN2HTT | |
| SCHEMBL8925288 | 0.76 | ELANE (0.49) | ELANEALDH1A1RAB9ASMN1; SMN2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2130817-B1 | Polymerizable Type II photoinitiators and curable compositions | AGFA GRAPHICS NV (BE) | 2016-01-06 | — | — | EP | disclosed |
| CN-102056890-B | Polymerizable type II photoinitiators and curable compositions | AGFA GRAPHICS NV | 2015-02-04 | — | — | CN | disclosed |
| US-8389769-B2 | Polymerizable type II photoinitiators and curable compositions | AGFA GRAPHICS NV (BE) | 2013-03-05 | — | — | US | disclosed |
| US-8362101-B2 | Multifunctional type II photoinitiators and curable compositions | AGFA GRAPHICS NV (BE) | 2013-01-29 | — | — | US | disclosed |
| US-20110069130-A1 | MULTIFUNCTIONAL TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS | AGFA GRAPHICS NV (BE) | 2011-03-24 | — | — | US | disclosed |
| US-20110063388-A1 | POLYMERIZABLE TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS | AGFA GRAPHICS NV (BE) | 2011-03-17 | — | — | US | disclosed |
| WO-2009147054-A1 | MULTIFUNCTIONAL TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS | AGFA GRAPHICS NV (BE) | 2009-12-10 | — | — | WO | disclosed |
| WO-2009147057-A1 | POLYMERIZABLE TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS | AGFA GRAPHICS NV (BE) | 2009-12-10 | — | — | WO | disclosed |
| EP-2130818-A1 | Multifunctional Type II photoinitiators and curable compositions | AGFA Graphics NV (BE) | 2009-12-09 | — | — | EP | disclosed |
| EP-2130817-A1 | Polymerizable Type II photoinitiators and curable compositions | AGFA Graphics NV (BE) | 2009-12-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110069130-A1 | MULTIFUNCTIONAL TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS | CRKL, CYTH2, CCNH | NAAA 4360/4885ELANE 4060/4885ALDH1A1 1579/4885 |
| US-20110063388-A1 | POLYMERIZABLE TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS | CCNH, CRKL, ERH | NAAA 3905/4885ELANE 4439/4885ALDH1A1 1584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.